CUBIST PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Three
CUBIST PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $110.72 million as of 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2014-11-07
- 2014-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $110.72M.
- 2014-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $110.72M.
- 2014-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $63.46M.
- 2013-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $63.46M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2014-09-30 | $110.72M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $110.72M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $63.46M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $63.46M 10-K · filed 2014-02-25 |
| 2013-09-30 | $20.73M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $20.73M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $20.73M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $20.73M 10-K · filed 2013-02-27 |
| 2012-09-30 | $20.87M 10-Q · filed 2012-11-05 |